FDA NDC Directory · JSON-LD · Markdown

Diazoxide

NDC 13517-100 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namediazoxide
Labeler / Manufacturere5 Pharma, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA211050
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDIAZOXIDE (50 mg/mL)
Marketing started20191211
Package count1

External sources

Source: openFDA. Public-domain (CC0).